Meningeome: Studien
Allgemeines
Quellen
Double-Blind Phase III Randomized Trial of the Antiprogestin Agent Mifepristone in the Treatment of Unresectable Meningioma: SWOG S9005.
J Clin Oncol 2015;33:4093-4098
DOI: 10.1200/JCO.2015.61.6490
| zurück Home | Meningeome: Studien | |
| Allgemeines |
||
| SWOG S9005 | Das Anti-Progesteron Mifepriston konnte die Prognose von inoperablen Meningeomen nicht verbessern(1). | |
| ARO 2015-2, PANAMA | Proton dose escalation for patients with atypical or anaplastic meningiomas, Phase II. Krause, Dresden | |
Quellen |
1.) Ji Y, et al.: Double-Blind Phase III Randomized Trial of the Antiprogestin Agent Mifepristone in the Treatment of Unresectable Meningioma: SWOG S9005. J Clin Oncol 2015;33:4093-4098 DOI: 10.1200/JCO.2015.61.6490 |
|
| ||
Impressum Zuletzt geändert am 24.01.2016 18:02